Cancer Immunology – News and Features
News
Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
Two companies have entered into an asset sale agreement relating to Cell Genesys' lentiviral gene delivery technology.
News
Idera and Merck KGaA to Collaborate on Development of TLR9 Agonists for Treatment of Cancer
Idera has agreed to exclusively license the therapeutic oncology applications, excluding cancer vaccines, of its lead TLR9 agonists.
News
University Hospitals Researchers Initiate Gene Therapy Trial in Patients with Advanced Skin Cancer
Gene therapy treatment aimed to boost immune system to fight deadly disease.
News
ImmunoVaccine Technologies to Acquire Immunotope
The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
News
St. Jude Finds Molecule that Could Improve Cancer Vaccines and Therapy for Other Diseases
Investigators have discovered a new signaling molecule that prevents immune responses from running amok and damaging the body.
News
Inovio Biomedical Redirects Strategic Emphasis Toward DNA Vaccines and DNA Delivery
Company expanding R&D to advance its DNA delivery technology and develop proprietary DNA vaccines for cancer and chronic infectious diseases.
News
Inovio Biomedical’s DNA Delivery Technology Enhances Potency of Gene-Based Prostate Cancer Vaccine
Data from a clinical study of DNA-based prostrate cancer demonstrated that Inovio’s DNA delivery technology enhanced the potency of the gene-based vaccine.
News
Geron Scientists and Collaborators Differentiate Human Embryonic Stem Cells into Insulin-Producing Islet-Like Clusters
The study shows that human embryonic stem cells can be transformed into the pancreatic cells that produce insulin that can offer the potential to treat diabetes.
News
Inovio Biomedical to Present DNA Delivery Technology at Drug Delevery Conference
Inovio’s Executive Director will present key aspects of non-viral DNA delivery at Arrowhead Drug Delivery 2007 in San Francisco.
News
Immune response to Cancer Stem Cells may Dictate Cancer’s Course
A new study shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease.
Advertisement
